Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

NCT04524507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: High-titer Convalescent COVID-19 Plasma (CCP1)
BIOLOGICAL: Standard-titer Convalescent COVID-19 plasma (CCP2)

Sponsor

University of North Carolina, Chapel Hill